• Meropenem in Translational Research: Mechanisms, Models, and

  2026-04-29

  This article offers translational researchers an integrated, mechanistic, and strategic perspective on Meropenem as a β-lactam antibiotic carbapenem for combating Gram-negative and Gram-positive bacterial infections. By bridging molecular insights with experimental design and resistance modeling, it contextualizes Meropenem’s unique value—especially as resistance mechanisms proliferate—using recent transmission data from clinical isolates. The discussion advances beyond standard product summaries, uncovering actionable protocols, evidence-backed guidance, and next-generation research opportunities for APExBIO’s Meropenem (SKU: A5124).

• HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Protoc

  2026-04-28

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides a reliable solution for generating high-yield, randomly Cy3-labeled RNA probes suitable for sensitive fluorescent detection in in situ hybridization and Northern blot assays. This kit is best used for research applications focusing on RNA localization and expression, and it is not validated for diagnostic or therapeutic purposes.

• Super-Enhancer Hijacking of LINC01977 Drives Early LUAD via

  2026-04-28

  Zhang et al. identified that super-enhancer-mediated activation of the long noncoding RNA LINC01977 promotes malignancy in early-stage lung adenocarcinoma (LUAD) through the canonical TGF-β/Smad3 pathway. This work reveals a feedback loop involving tumor-associated macrophage infiltration and offers a new epigenetic target for early LUAD intervention.

• Hexetidine (NSC-17764): Optimizing Oral Biofilm Inhibition A

  2026-04-27

  Hexetidine (NSC-17764) is a broad-spectrum antimicrobial agent uniquely effective against planktonic and biofilm forms of oral pathogens, with robust performance in dental and device-associated infection models. This article delivers stepwise protocols, advanced troubleshooting, and insights from recent biofilm research, empowering labs to maximize reliability in oral infection and biofilm inhibition assays.

• Necroptosis Triggers IFN-Dependent Anti-Tumor Immunity in Mi

  2026-04-27

  This study establishes that necroptosis, a regulated form of cell death, robustly stimulates protective anti-tumor immunity through type I interferon signaling and CD4+ T cell responses. By using a system that distinguishes necroptosis from apoptosis with minimal confounding inflammation, the authors clarify necroptosis’s unique immunogenic potential for cancer immunotherapy research.

• Synergistic Suppression of Pancreatic Tumor Growth by CDK4/6

  2026-04-26

  Gu et al. (2025) reveal that combining the CDK4/6 inhibitor PD 0332991 (Palbociclib) with a BET inhibitor yields synergistic suppression of pancreatic ductal adenocarcinoma (PDAC) growth and reverses epithelial-to-mesenchymal transition. Their mechanistic insights highlight a critical role for the GSK3β-mediated Wnt/β-catenin pathway, providing a rationale for dual-targeted strategies in PDAC research.

• Strategic Apoptosis Detection: Mechanistic Insight to Transl

  2026-04-25

  This thought-leadership article bridges foundational apoptosis mechanisms and translational strategy, empowering researchers to leverage the Annexin V-Cy5/DAPI Apoptosis Kit for mechanistically-informed, reproducible cell death analysis. By integrating recent advances in leukemia signaling and workflow optimization, we chart a path from bench to bedside for apoptosis detection.

• Caspase-3 Colorimetric Assay Kit: Applied Workflows & Tips

  2026-04-24

  The Caspase-3 Colorimetric Assay Kit enables fast, quantitative apoptosis detection with superior sensitivity and workflow simplicity. This guide bridges experimental design, advanced troubleshooting, and recent immunology findings to help researchers leverage the full power of this DEVD-pNA substrate assay.

• LBP Promotes AMPK/PINK1/Parkin Mitophagy in Sarcopenic Obesi

  2026-04-24

  This study reveals that Lycium barbarum polysaccharide (LBP) counteracts skeletal muscle atrophy induced by a high-fat diet by activating the AMPK/PINK1/Parkin-mediated mitophagy pathway. These findings provide mechanistic insight into LBP's potential for regulating energy metabolism and mitigating obesity-related muscle degeneration.

• OsCDPK24/28-OsHSFA4d Phosphorylation Coordinates Stress in R

  2026-04-23

  This study uncovers how rice calcium-dependent protein kinases OsCDPK24 and OsCDPK28 directly phosphorylate the heat shock factor OsHSFA4d, integrating plant responses to both heat and pathogen stress. These mechanistic insights redefine the molecular trade-off between thermotolerance and immunity, informing strategies for crop resilience under climate change.

• Cell Surface GlycoRNA–RBP Domains Enable Peptide Entry: New

  2026-04-23

  This study reveals that RNA binding proteins (RBPs) and glycoRNAs form nanoclusters on the cell surface, which facilitate the entry of cell-penetrating peptides. These findings redefine our understanding of the cell surface landscape and open new avenues for targeted delivery, surface interactome mapping, and selective labeling strategies.

• FGF, FGFR, and CCND1 Methylation in HNSCC: Biomarker and Inh

  2026-04-22

  Bao et al. (2021) systematically mapped DNA methylation patterns across FGF, FGFR, and CCND1 genes in head and neck squamous cell carcinoma (HNSCC), correlating these epigenetic marks with gene expression, amplification, HPV status, and response to FGFR tyrosine kinase inhibitors. Their findings identify methylation signatures—especially near the CCND1 transcription start site—associated with sensitivity to inhibitors like PD 173074, highlighting the potential of methylation as a predictive biomarker for targeted therapy.

• Drosophila Keap1 Forms Nuclear Condensates in Oxidative Stre

  2026-04-22

  This study reveals that Drosophila Keap1 (dKeap1) assembles into nuclear condensates in response to oxidative stress, requiring both its N- and C-terminal domains. The work uncovers a nuclear mechanism for dKeap1 involving intrinsically disordered regions, with implications for understanding chromatin regulation during stress and development.

• AI-Derived Prognostic Signature Enhances HCC Risk Stratifica

  2026-04-21

  This study introduces a robust consensus artificial intelligence-derived prognostic signature (CAIPS) for hepatocellular carcinoma (HCC), leveraging multi-omics data and ten machine learning algorithms across six cohorts. The CAIPS model outperforms traditional clinical parameters in prognostic accuracy and identifies actionable therapeutic targets to inform precision oncology.

• A-1210477: Precision MCL-1 Inhibitor for Cancer Cell Apoptos

  2026-04-21

  A-1210477 is a potent, selective MCL-1 inhibitor that enables targeted induction of apoptosis in MCL-1-dependent cancer cells. This guide translates the latest mechanistic insights and reference-backed protocols into actionable workflows, troubleshooting strategies, and advanced applications for cancer research.

452 records 20/31 page Previous Next First page 上5页 1617181920 下5页 Last page